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doi:10.1Objective: For aortic arch aneurysms, conventional total arch replacement has been the standard surgical
option. In selected high-risk patients, we have attempted less invasive hybrid procedure involving supra-
aortic bypass and endovascular stent-graft placement. We review the early and midterm outcomes to clarify
the impact of the hybrid procedure.
Methods: Between October 2007 and December 2010, 27 patients were treated with the hybrid procedure. Dur-
ing the same period, 191 patients underwent elective conventional total arch replacement. On retrospective anal-
ysis, the hybrid procedure was feasible in 103 patients (hybrid feasible) and not feasible in 88 patients (hybrid
impossible). Patients undergoing the hybrid procedure attained significantly higher additive (11.6 2.2 vs 9.5
2.4, 10.3  2.8, P<.001, P ¼ .044) and logistic (31.1  14.1 vs 18.8  12.6, 23.7  16.0, P<.001, P ¼ .047)
European System for Cardiac Operative Risk Evaluation scores than hybrid-feasible and hybrid-impossible
groups.
Results: Although the patients in the hybrid group had significantly higher risk, the early outcomes including
mortality and morbidity were similar among the 3 groups, as were the 2-year survivals during the follow-up pe-
riod: 85.9% for the hybrid group, 89.6% for the hybrid-feasible group, and 86.7% for the hybrid-impossible
group (P¼ .510, .850, log-rank test). In the hybrid group, 2 patients required reintervention for type I endoleak.
Conclusions: The early and midterm outcomes of the hybrid procedure for aortic arch aneurysms were satisfac-
tory. This procedure has the potential to be an alternative for conventional total arch replacement for high-risk
patients. (J Thorac Cardiovasc Surg 2012;143:1007-13)Conventional total arch replacement (TAR) using cerebral
perfusion with hypothermia for brain protection has been
the standard surgical option for aortic arch aneurysms,
although it remains associated with some morbidity and
mortality despite improved surgical technology.1 Cardio-
pulmonary bypass (CPB) is associated with a strong sys-
temic inflammatory response and substantial myocardial
injury, especially in high-risk subgroups.2 Moreover, deep
hypothermic circulatory arrest can result in some perma-
nent neurologic injury.3
Thoracic endovascular aortic repair (TEVAR) has
recently been recognized as an alternative treatment for tho-
racic aortic aneurysms. This less invasive technique has also
been used for aortic arch aneurysms using a supra-aortic by-
pass (hybrid arch TEVAR) with reportedly successful out-
comes.4-9 Czerny and colleagues10 reported good midterme Department of Cardiovascular Surgery, National Cerebral and Cardiovascu-
enter, Osaka, Japan.
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The Journal of Thoracic and Carresults with supra-aortic transpositions for extended endo-
vascular repair of aortic arch aneurysms. Milewski and col-
leagues11 also reported the comparative study of elective
open arch debranching with endovascular stent placement
and conventional total and distal aortic arch reconstruction.
They concluded that the hybrid procedure had a lower mor-
tality in patients aged more than 75 years.
We used this technique for patients who had significantly
high risk factors for conventional TAR. The aim of this
study was to evaluate the early and midterm outcomes of
hybrid arch TEVAR and to compare themwith those of con-
ventional TAR.MATERIAL AND METHODS
Patient Population
In October 2007, we started performing hybrid arch TEVAR for aortic
arch pathologies in selected high-risk patients. For these patients, conven-
tional TAR was difficult because of some surgical risks, for example, ad-
vanced age and some significant comorbidities of cerebrovascular
disease, left ventricular dysfunction, history of cardiac surgery, pulmonary
dysfunction, chronic renal failure, severely compromised daily life, and
short life expectancy due to malignancy. Between October 2007 and
December 2010, we performed hybrid arch TEVAR in 27 patients
(hybrid-repair) with high risks. All operations were performed electively.
The early and midterm outcomes were reviewed.
During the same period, we electively performed conventional TAR in
191 patients. We retrospectively evaluated their aortic morphology anddiovascular Surgery c Volume 143, Number 5 1007
Abbreviations and Acronyms
BCA ¼ brachiocephalic artery
CPB ¼ cardiopulmonary bypass
CT ¼ computed tomography
ePTFE ¼ expanded polytetrafluoroethylene
euroSCORE ¼ European System for Cardiac
Operative Risk Evaluation
LAxA ¼ left axillary artery
LCCA ¼ left common carotid artery
LSCA ¼ left subclavian artery
RAxA ¼ right axillary artery
RCCA ¼ right common carotid artery
TAR ¼ total arch replacement
TEVAR ¼ thoracic endovascular aortic repair
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Dbackground, such as risk factors and comorbidities. The hybrid arch TE-
VARwas not indicated in 88 patients primarily because of dilatation or dis-
section of proximal landing zone and sometimes younger age, infective
aortic aneurysm, connective tissue disease, and need for concomitant car-
diac procedures, such as valve replacement or coronary artery bypass graft-
ing (hybrid-impossible group). For the remaining 103 patients, hybrid arch
TEVAR or TAR was indicated in the assessment from the surgical aspect
(hybrid-feasible group). We compared the outcomes of these 3 groups to
justify this less-invasive procedure.
All patients underwent risk stratification according to European System
for Cardiac Operative Risk Evaluation (euroSCORE) guidelines.12 Both
additive and logistic values were collected because the logistic euro-
SCORE has been reported to be a better risk predictor for high-risk pa-
tients.13 Preoperative patient characteristics (Table 1) showed that
patients in the hybrid-repair group were significantly older than patients
in the hybrid-feasible group (76.6  10.6 years vs 71.3  8.0 years,
P ¼ .005). The significantly older age and higher rate of neurologic dys-
function (30% vs 2.9%, P<.001) resulted in a higher euroSCORE: The
additive euroSCOREwas 11.6 2.2 vs 9.5 2.4, P<.001, and the logistic
euroSCORE was 31.1 14.1 vs 18.8 12.6, P<.001. Ischemic heart dis-
ease (56% vs 18%, P<.001) was more prevalent in the hybrid arch TE-
VAR group. Patients undergoing hybrid arch TEVAR also had a higher
euroSCORE than the hybrid-impossible group (additive euroSCORE,
10.3  2.8; P ¼ .044; logistic euroSCORE, 23.7  16.0; P ¼ .047).
The data analysis was approved by the institutional review board of the
National Cerebral and Cardiovascular Center, and the board waived the
need for patients’ consent.
Preoperative Evaluation
Preoperative evaluation was made by multislice computed tomography
(CT) scans to predict the required length of the proximal landing zone after
the supra-aortic bypass because an adequate proximal landing zone is es-
sential for successful stent-graft placement. Furthermore, these CT scans
help to exclude major occlusive disease of the supra-aortic branches and
the aorto-iliac axis for arterial access for stent-graft insertion.
We chose the fashion of supra-aortic bypass appropriately according to
an adequate proximal landing zone and inflow artery.14 The details of the
operative procedure are shown in Table 2. The supra-aortic bypass was per-
formed once the proximal landing zone had been established between
zones 0 and 2. To ensure an adequate proximal landing zone of more
than 2 cm in length, we aggressively chose zone 1 instead of zone 2. In
this setting, only extrathoracic supra-aortic bypasses were required and
less invasiveness could be preserved. However, in 4 cases with a proximal1008 The Journal of Thoracic and Cardiovascular Surlanding length less than 2 cm for the zone 1 landing, we alternatively could
not avoid choosing the zone 0 landing. For this, median sternotomy and
side-clamp of the ascending aorta for the anastomosis of the inflow site
were required. We indicate this procedure in patients with an intact ascend-
ing aorta who are expected to be healthy enough for the sternotomy but
have risks for CPB.
The distal landing site was between T3 and T7 in 21 patients and be-
tween T8 and T11 in 6 patients.
Subset analysis for each hybrid reconstruction is shown in Table 3.
There was no significant difference in patients’ characteristics among the
3 groups.
Surgical Procedures of the Hybrid Arch Thoracic
Endovascular Aortic Repair
Zone 0. After a median sternotomy and systemic heparinization, the
ascending aorta was partially clamped and a straight Dacron prosthesis
(10–14 mm in diameter) was sewn in a side-to-end fashion. The brachioce-
phalic artery (BCA) and left common carotid artery (LCCA) were clamped
and divided while the mean systemic blood pressure was increased to more
than 80 mm Hg and then reconstructed in an end-to-end fashion. The left
subclavian artery (LSCA) was reconstructed in an end-to-end fashion
near its origin or the left axillary artery (LAxA) was reconstructed in
a side-to-end fashion at the axillar portion. The origin of the LSCA was
closed by coil embolization after TEVAR. The clamp times for BCA and
LCCA were 8.3 minutes (range, 7–10 minutes) and 7.5 minutes (range,
7–8 minutes), respectively.
Zone 1. The right common carotid artery (RCCA) or right axillary ar-
tery (RAxA) was chosen as the inflow artery. The RCCA and LCCA
were exposed through the middle cervical incision, and the RAxAwas ex-
posed at the subclavicular incision. The LAxAwas exposed at the supracla-
vicular incision when the RCCAwas the inflow artery for the bypass and
through the subclavicular incision when the RAxA was the inflow artery.
After systemic heparinization, a branched-type 8-mm expanded polytetra-
fluoroethylene (ePTFE) graft was anastomosed. The clamp times for
RCCA and LCCAwere 12.1 minutes (range, 8–17 minutes) and 7.6 min-
utes (range, 5–10 minutes), respectively.
Zone 2. Both of the AxAs were exposed under the subclavicular inci-
sion. An ePTFE graft of 8 mm was sutured onto both AxAs.
The transfemoral approach was selected as the access route for stent-
graft placement for 5 patients. The native external iliac artery was selected
for the approach for 7 patients, and a conduit with an 8-mm or 10-mm Da-
cron graft placed at the origin of the external iliac artery for the access route
was used for 15 patients.
The Gore TAG (WL Gore & Associates, Inc, Flagstaff, Ariz) was used
in 21 patients, the Talent (Medtronic Inc, Santa Rosa, Calif) was used in 3
patients, and a Matsui-Kitamura stent-graft (Kitamura Inc, Kanazawa,
Japan) was used in 1 patient. Both the Gore TAG and the Talent devices
were used in 2 patients. An average of 1.4 devices were used (range, 1–3).
The completed status of the supra-aortic bypass and TEVAR placement is
shown in Figures 1 to 3.
For prevention of supra-aortic graft occlusion, all patients were given
low-dose aspirin. Patients who had severely diseased arteries or who had
undergone reconstruction of the left vertebral artery were given Coumadin.
Surgical Procedure of Conventional Total Arch
Replacement
All patients underwent a median sternotomy for the establishment of
CPB bymeans of RAxA perfusion in addition to femoral or ascending aorta
perfusion.15 Patients were cooled to a core temperature of 20C to 28C.
Antegrade selective cerebral perfusion was used for cerebral safety. In
most cases, a distal aortic anastomosis was created with a stepwise tech-
nique,16 and for arch reconstruction, a 4-branched graft was attached to
the stepwise graft. This was followed by antegrade aortic perfusion. Aftergery c May 2012
TABLE 1. Comparison of patients’ characteristics
Hybrid repair
(n ¼ 27)
Hybrid feasible
(n ¼ 103)
Hybrid impossible
(n ¼ 88)
P value
(repair vs feasible)
P value
(repair vs impossible)
Age (y) 76.6  10.6 71.3  8.0 73.3  8.9 .005 .154
Male:female 22:5 79:24 62:26 .595 .378
Additive euroSCORE 11.6  2.2 9.5  2.4 10.3  2.8 <.001 .044
Logistic euroSCORE 31.1  14.1 18.8  12.6 23.7  16.0 <.001 .047
Chronic pulmonary disease 2 (7.4%) 15 (15%) 5 (5.7%) .509 .895
Extracardiac arteriopathy 13 (48%) 2 (31%) 8 (9.1%) .097 <.001
Neurologic dysfunction 8 (30%) 3 (2.9%) 5 (5.7%) <.001 .002
History of cardiac surgery 1 (3.7%) 9 (8.7%) 10 (11%) .640 .418
Serum creatinine>2.0 mg/dL 4 (15%) 8 (7.8%) 7 (8.0%) .452 .493
LVEF<50% 4 (15%) 5 (4.9%) 14 (16%) .165 .868
Ischemic heart disease 15 (56%) 19 (18%) 37 (42%) <.001 .311
LVEF, Left ventricular ejection fraction.
TABLE 3. Subset analysis for each particular hybrid reconstruction
Zone 0
(n ¼ 4)
Zone 1
(n ¼ 19)
Zone 2
(n ¼ 4)
Age (y) 80.0  13.4 75.2  10.7 79.8  8.0
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Dthe LSCAwas reconstructed with a branch graft, rewarming was initiated.
The proximal anastomosis was constructed above the sinotubular junction.
Finally, the LCCA and BCAwere reconstructed and each anastomosis was
deaired before release of the distal clamp.
Data Definitions
This comprises a retrospective analysis of prospectively collected data.
Patients’ risk factors were defined according to the euroSCORE calcula-
tor,12 which defines chronic obstructive pulmonary disease as long-term
use of bronchodilators, steroids for lung disease, or less than 70% of 1 sec-
ond forced expiratory volume rate. Extracardiac arteriopathy is defined as
the presence of 1 or more claudications, carotid occlusions or greater than
50% stenosis, and previous or planned intervention on the abdominal, limb
arteries, or carotids. Neurologic dysfunction is defined as a disease severely
affecting ambulation or day-to-day functioning, left ventricle ejection frac-
tion is calculated by using the findings of transthoracic echocardiography,
and ischemic heart disease is defined as a history of coronary artery inter-
vention, history of coronary artery bypass grafting, and more than 75% ste-
nosis of coronary arteries.
For postoperative mortality and morbidity, stroke was defined as perma-
nent neurologic deficit caused by brain ischemia, embolism, thrombosis, or
hemorrhage, and transient neurologic deficit was defined as the presence of
abnormalities such as delirium or convulsion from which the patients even-
tually recovered. Renal failure was defined as new need for hemodialysis.
Graft infection was diagnosed by examining CT scans or purulence drained
from the prosthesis.
Statistical Analysis
The patients were followed up at the outpatient clinic or with a telephone
survey, and the follow-up was completed for all patients. The median
follow-up duration was 7 months (range, 1–27 months). The continuous
data in this study are expressed as mean  standard deviation and range.
Survival and freedom from aorta-related events were calculated with theTABLE 2. Details of supra-aortic bypass
Supra-aortic bypass n
Zone 0 Asc - BCA - LCCA - LSCA (LAxA) 3
Asc–RAxA - LCCA - LSCA (LAxA) 1
Zone 1 RAxA - LCCA - LAxA 11
RCCA - LCCA - LAxA 7
LAxA - RCCA - RAxA 1
Zone 2 RAxA–LAxA 4
Asc, Ascending aorta.
The Journal of Thoracic and CarKaplan–Meier method. Statistical analysis was performed with StatView
(SAS Institute, Inc, Cary, NC).RESULTS
In the hybrid arch TEVAR group, there was 1 in-hospital
death (3.7%). Cerebellar infarction during the preceding
RCCA-LCCA-LAxA bypass surgery developed in this pa-
tient, who had a shaggy aorta. In the staged TEVAR, multi-
ple embolism of liver, spleen, spine, and legs also occurred.
The patient died 5 months after the operation. In another pa-
tient, cerebral infarction that caused quadrantanopia was
detected. Stroke was encountered in these 2 patients
(7.4%), and no transient neurologic deficit was observed
in the hybrid arch TEVAR group.
No brain damage was caused by the short-time clamp of
the BCA and common carotid artery. However, in 2 patients
(7.4%), including the patient described above, paraplegia
occurred after TEVAR. Another patient had both distal
arch and descending aortic aneurysms. Two stent grafts
were placed to cover from zone 1 to T11. The motor-
evoked potentials weakened during the skin closure.
Paraplegia was not relieved, although cerebrospinal fluidMale:female 4:0 16:3 2:2
Additive euroSCORE 11.3  2.4 11.4  2.1 13.0  2.2
Logistic euroSCORE 27.1  12.2 30.4  13.7 38.5  18.5
Chronic pulmonary disease 0 (0%) 2 (11%) 0 (0%)
Extracardiac arteriopathy 2 (50%) 8 (42%) 3 (75%)
Neurologic dysfunction 1 (25%) 6 (32%) 1 (25%)
History of cardiac surgery 0 (0%) 1 (5.3%) 0 (0%)
Serum creatinine>2.0 mg/dL 0 (0%) 3 (16%) 1 (25%)
LVEF<50% 0 (0%) 3 (16%) 1 (25%)
Ischemic heart disease 3 (75%) 9 (47%) 3 (75%)
LVEF, Left ventricular ejection fraction.
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FIGURE 1. Postoperative 3-dimensional CT scan of hybrid arch TEVAR
for zone 0. Supra-aortic bypass was made from the ascending aorta to the
BCA, LCCA, and LAxA.
FIGURE 2. Postoperative 3-dimensional CT scan of hybrid arch TEVAR
for zone 1. Supra-aortic bypass was made from the RAxA to the LCCA and
LAxA.
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Ddrainage with steroid therapy was performed. In 3 patients
(11%), the injuries of the iliac arteries (the access route
for TEVAR) were treated by graft replacement.
The median operation time including both bypass and
TEVAR was 388 minutes (range, 212–540 minutes). No
CPB was used. Eighteen of 27 patients (67%) required
transfusion.
The 2-year survival calculated by the Kaplan–Meier
method was 85.9% in the hybrid arch TEVAR group.
Two patients died of pneumonia 3 months and 4 months
after TEVAR. In 2 patients, reinterventions for type I
endoleak were necessary after TEVAR with additional
supra-aortic bypasses and TEVAR. No occlusion of the
supra-aortic bypass was detected during the following
period. No proximal dissection of the aorta was detected
after TEVAR.
An outcome comparison of the 3 groups is shown in
Table 4. The 30-day mortality (none vs 1.9% vs 2.3%,
P ¼ .881, .959) and in-hospital mortality (3.7% vs 7.8%
vs 8.0%, P ¼ .753, .744) were similar. The incidences of
stroke did not differ, but stroke tended to be more severe af-
ter TAR and resulted in deterioration of patients’ activity.
The requirement of tracheostomy and postoperative renal
insufficiency were similar. The length of stay in the inten-
sive care unit was significantly shorter in the hybrid repair
group (1.6  1.3 days vs 5.6  9.0 days vs 7.0  9.8
days, P ¼ .024, .006). The midterm survival after the dis-
charge calculated by the Kaplan–Meier method is shown
in Figure 4. There was no significant difference among
the 3 groups (P ¼ .510, .850, log-rank test).1010 The Journal of Thoracic and Cardiovascular SurDISCUSSION
The surgical outcome for aortic arch aneurysm has im-
proved consistently. When balancing operative risk and an-
atomic suitability for less invasive endovascular treatment,
TEVAR would be the most appropriate option for some pa-
tients who have complicated multiple medical comorbid-
ities.17 Less invasive techniques for aortic arch repair with
TEVAR are in demand because conventional TAR involves
general anesthesia, median sternotomy, CPB, cerebral
perfusion, and hypothermic circulatory arrest for systemic
organ protection. Newer surgical alternatives that incorpo-
rate emerging endovascular techniques have the potential
to transform the way we manage the aortic arch. In terms
of TEVAR for arch aneurysms, there have been 2 ap-
proaches: the presented hybrid arch TEVAR and the TE-
VAR with a fenestrated or branched stent-graft. At the
National Cerebral and Cardiovascular Center, a fenestrated
or branched stent-graft cannot be used for TEVAR. The
hybrid approach with the preceding supra-aortic bypass
has been used as less invasive arch repair.gery c May 2012
FIGURE 3. Postoperative 3-dimensional CT scan of hybrid arch TEVAR
for zone 2. Supra-aortic bypass was made from the RAxA to the LAxA.
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midterm outcomes of similar hybrid arch TEVAR using
surgical debranching of the supra-aortic branches, followed
by the endovascular repair. Our outcome was coincident to
those of the other reports. However, we used this less inva-
sive hybrid arch TEVAR for selected high-risk patients in
situations in which conventional TAR had a satisfactoryTABLE 4. Comparison of outcomes
Hybrid repair
(n ¼ 27)
Hybrid feasible
(n ¼ 103)
H
30-d mortality 0 (0%) 2 (1.9%)
In-hospital mortality 1 (3.7%) 8 (7.8%)
Stroke 2 (7.4%) 5 (4.9%)
Transient neurologic deficit 0 (0%) 8 (7.8%)
Permanent paraplegia 2 (7.4%) 0 (0%)
Need for tracheostomy 1 (3.7%) 5 (4.9%)
Renal failure 1 (3.7%) 1 (1.0%)
Gastrointestinal bleeding 1 (3.7%) 2 (1.9%)
Reoperation for bleeding 2 (7.4%) 3 (2.9%)
Vascular injury 3 (11%) 0 (0%)
Graft infection 0 (0%) 2 (1.9%)
Intensive care unit stay (d) 1.6  1.3 5.6  9.0
The Journal of Thoracic and Caroutcome with low mortality and cerebral morbidity.18 In
the retrospective comparative study, the outcomes did not
differ, although the hybrid arch TEVAR group had a signif-
icantly higher risk than the conventional TAR group. There
have been few similar reports comparing the surgical out-
come of the hybrid arch TEVAR and that of conventional
TAR. Milewski and colleagues11 also reported the compar-
ative study and concluded that the hybrid procedure may be
a safe alternative to open repair; however, their treatment
strategy was different from ours. They more aggressively
created the proximal inflow anastomosis on the ascending
aorta with the zone 0 approach in all cases via a median ster-
notomy with or without CPB. On the other hand, in the ma-
jority of our patients, the proximal landing zones were zone
1 or 2 where the patency of BCAwas preserved and the ex-
trathoracic supra-aortic bypass could be used. In 4 patients
who required the proximal landing at the zone 0, the inflow
was made on the ascending aorta via a median sternotomy,
because all of the patients have higher surgical risks. Wei-
gang and colleagues19 also reported 26 cases of hybrid
arch TEVAR. They performed an ascending aorta to bilat-
eral carotid bypass using an inverse bifurcated prosthesis
without CPB and deep hypothermic circulatory arrest.
Four patients (15%) died of perioperative cardiovascular
adverse events. One of the main dangers is the construction
of the end-to-side ascending aortic anastomosis. Szeto and
colleagues20 addressed the need for CPB before tangen-
tially clamping the ascending aorta. We believe that if nec-
essary, more aggressive zone 0 approaches might be
justified when the ascending aorta is assumed to be safely
side-clamped.
With regard to postoperative neurologic sequelae, less se-
vere neurologic injury occurred in the hybrid arch TEVAR
group than in the TAR group. Potential explanations for
these findings are careful preoperative evaluation of the
brain-supplying vessel, choice of the safe crossclamp and
anastomosis site with CT scans and direct echocardiogra-
phy, meticulous anastomosis, and short crossclampingybrid impossible
(n ¼ 88)
P value
(repair vs feasible)
P value
(repair vs impossible)
2 (2.3%) .881 .959
7 (8.0%) .753 .744
4 (4.5%) .965 .928
2 (2.3%) .296 .959
0 (0%) .057 .083
2 (2.3%) .794 .778
2 (2.3%) .881 .778
1 (1.1%) .859 .959
2 (2.3%) .604 .501
0 (0%) .007 .013
2 (2.3%) .882 .959
7.0  9.8 .024 .006
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FIGURE4. Kaplan–Meier survival curve. TEVAR,Thoracic endovascular
aortic repair.
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Dtimes of the brain-supplying vessels. Minor strokes, pre-
sumably due to embolism, were observed in only 2 patients.
Without doubt, the risk of embolism is present in all these
procedures, and careful manipulations and a crossclamp
time short are mandatory.
Our data revealed that hybrid arch TEVAR is indicated
for obviously ‘‘high-risk’’ patients. Whether the indication
of this procedure will be extended to low- or mid-risk pa-
tients is the next issue to be investigated. There has been
no report that shows long-term results of hybrid procedure.
If the long-term durability of this procedure is established,
the indication would be extended. Long-term durability can
be greatly influenced by the presence of postoperative type I
endoleak, required reintervention, and the patency of supra-
aortic bypass. In patients with type I endoleak, the follow-
ing points are crucial in preventing it: (1) If the proximal
landing at zone 2 is assumed to be difficult, adequate prox-
imal landing zone should be obtained bymaking the landing
at zone 1 and performing bypass surgery to the LCCA. (2) A
stent-graft should be placed along the outer curvature of
aortic arch to prevent the migration of the stent-graft. (3)
When the BCA and LCCA have a common trunk (bovine
aorta), a stent-graft should be placed covering approxi-
mately one third of the origin of common trunk after
performing bypass surgery to the LCCA. Otherwise, new
devices for the controlled deployment are assumed to
have the possibility of reducing the defects of current com-
mercially available devices, such as proximal neck wall ap-
position (the ‘‘bird’s beak’’ effect) and aortic injury by the
bare stent at the tip.
In the long-term, occlusion or thrombi associated with
bypass grafting can lead to late neurologic complications.21
Byrne and colleagues22 analyzed 143 extra-anatomic proce-
dures for carotid and subclavian reconstruction. Most by-
pass grafts were made of ePTFE and the 5-year patency
rate was 92%, indicating that artificial bypass grafts can re-
sult in excellent patency rates. We also used ePTFE grafts
for most of our patients, and no graft occlusion was encoun-
tered during the follow-up period. However, we need1012 The Journal of Thoracic and Cardiovascular Surfurther close observation of the patency of the supra-
aortic bypass in association with low-dose (100 mg) aspirin
administration.
There are some limitations to this study. First, the size of
the cohort was small and the follow-up period was relatively
short. Second, this was a single-institution, retrospective
comparative study. There must be some potential bias in pa-
tient selection. Randomized controlled trials are thus desir-
able for accurate assessment of the best strategy for aortic
arch pathologies.CONCLUSIONS
The early and midterm outcomes of hybrid arch TEVAR
for aortic arch aneurysm were satisfactory. Hybrid arch
TEVAR has the potential to be a less invasive alternative
for conventional TAR.References
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